| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |